Bio-Rad Laboratories (BIO) Research & Development (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Research & Development for 18 consecutive years, with $61.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 1.16% year-over-year to $61.2 million in Q2 2026; TTM through Jun 2026 was $265.7 million, a 12.77% decrease from a year earlier, with the FY2025 full-year figure at $275.6 million, down 6.86% from the prior year.
• Research & Development was $61.2 million for Q2 2026 at Bio-Rad Laboratories, down from $62.9 million in the prior quarter.
• Over five years, Research & Development peaked at $91.0 million in Q3 2024 and troughed at $43.5 million in Q3 2023.
• A 5-year average of $66.7 million and a median of $65.6 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development plunged 34.84% in 2023 and surged 109.03% in 2024, its largest moves.
• Over 5 years, Research & Development stood at $66.2 million in 2022, then fell by 3.53% to $63.9 million in 2023, then rose by 24.62% to $79.6 million in 2024, then dropped by 11.68% to $70.3 million in 2025, then dropped by 12.94% to $61.2 million in 2026.
• The last three Research & Development figures came in at $61.2 million (Q2 2026), $62.9 million (Q1 2026), and $70.3 million (Q4 2025), per Business Quant data.